Skip to main content

Table 1 Autopsy case demographics

From: Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression

 

Age at Onset

Age at Death

Pathology Diagnosis

APOE

Braak Stage

Thal Phase

CERAD Score

IHC

Biochem

LBD

 Case 1

71

81

LBD/AD/CAA

ε3/ε3

V-VI

5

C3

A, C, M

 Case 2

60

68

LBD/AD/CAA

ε3/ε4

VI

5

C3

A, C, M

C

 Case 3

70

83

LBD/AD

ε3/ε4

VI

5

C3

A, C, M

 Case 4

70

80

LBD/AD

ε3/ε3

III

3

C2

A, C, M

 Case 5

73

80

LBD/AD

ε3/ε4

VI

5

C3

A, C, M

MTL

 Case 6

51

62

LBD/AD

ε3/ε3

II

5

C3

A, C, M

 Case 7

63

67

LBD/AD

ε3/ε4

III

4

C3

A, C, M

A, MTL

 Case 8

62

67

LBD/AD

ε3/ε4

III

3

C1

A, C, M

 Case 9

84

90

LBD/AD

ε3/ε3

III

5

C2

A, C, M

 Case 10

67

72

LBD/AD

ε2/ε3

V-VI

3

C2

C

 Case 11

59

66

LBD/AD/CAA

ε3/ε4

IV

2

C3

C

 Case 12

40

78

LBD/AD/CAA

ε3/ε3

IV

3

C3

MTL

 Case 13

64

74

LBD/AD/CAA

ε2/ε4

VI

5

C2

MTL

 Case 14

62

68

LBD/AD

ε4/ε4

V

3

C3

MTL

AD/ALB

 Case 15

(> 90)

(> 90)

AD/CAA

ε2/ε3

V-VI

3

C3

A, C, M

 Case 16

82

AD

ε2/ε3

III

3

C1

A, C, M

 Case 17

58

63

AD

ε3/ε3

VI

3

C3

A, C, M

 Case 18

75

83

AD/CAA

ε3/ε4

V

3

C2

A, C, M

 Case 19

62

77

AD/PSP

II

3

C2

A, C, M

 Case 20

57

64

AD/CAA

ε3/ε3

V

5

C3

A, C, M

MTL

 Case 21

40

77

AD/CAA

ε2/ε3

II

2

C2

A, C, M

MTL

 Case 22

(> 90)

(> 90)

AD/CAA

ε3/ε3

VI

4

C3

A, C, M

 Case 23

53

67

AD

ε3/ε3

VI

3

C3

A, C, M

Controls

 Case 24

87

No neurological diagnosis

ε2/ε3

0

0

0

MTL

 Case 25

56

67

FTLD-TDP

ε3/ε3

0

0

0

MTL

 Case 26

82

Cerebrovascular arteriolosclerosis

ε2/ε3

II

2

C1

C

 Case 27

52

No neurological diagnosis

ε3/ε4

II

2

C1

C

  1. LBD Lewy body dementia, AD Alzheimer’s disease, AD/ALB Alzheimer’s disease with Amygdala restricted Lewy bodies, CAA cerebral amyloid angiopathy, PSP progressive supranuclear palsy, FTLD-TDP frontotemporal lobar degeneration with TAR DNA-binding protein 43 inclusions, APOE apolipoprotein E, A amygdala, C cingulate cortex, M midbrain, MTL medial temporal lobe